Friday , June 23 2017
Breaking News
Home / Business / Alembic Pharmaceuticals reports marginal rise in Q4 consolidated net profit

Alembic Pharmaceuticals reports marginal rise in Q4 consolidated net profit

Alembic Pharmaceuticals has reported results for fourth quarter and year ended March 31, 2017.

The company has reported a fall of 33.21% in its net profit at Rs 59.24 crore for the quarter ended March 31, 2017 as compared to Rs 88.70 crore for the same quarter in the previous year. However, total income from operations of the company has increased by 9.98% at Rs 647.03 crore for quarter under review as compared to Rs 588.34 crore for the quarter ended March 31, 2016.

On consolidated basis, the company has reported marginal rise of 2.43% in its net profit after tax, share of profit/loss of associates & joint ventures and minority interest at Rs 93.04 crore for the quarter ended March 31, 2017 as compared to Rs 90.83 crore for the corresponding quarter in the FY16. Total income from operations of the company increased by 18.32% at Rs 741.35 crore for quarter under review as compared to Rs 626.58 crore for the same quarter ended previous year.

For the year ended March 31, 2017, the company has posted a fall of 38.37% in its net profit at Rs 430.63 crore as compared to Rs 698.74 crore in FY16. Total income of company decreased marginally by 0.77% at Rs 2985.90 crore for year under review as compared to Rs 3009.02 crore for the year ended March 31, 2016.

For the year ended March 31, 2017, on the consolidated basis, the company has posted a fall of 44.01% in its net profit after tax, share of profit/loss of associates & joint ventures and minority interest at Rs 403.16 crore as compared to Rs 720.04 crore in the previous year. Total income from operations of company has decreased marginally by 0.99% at Rs 3134.61 crore for year under review as compared to Rs 3165.99 crore for the year ended March 31, 2016.

About editor